1 (download XLSX Statistical source data
A typical weekly research dose of 6mg (2mg three times weekly) represents approximately 0.027% of the estimated toxic dose
Take 4 ml (0.81 tsp) daily or as directed by your healthcare practitioner
Heres what we do know from the few human reports available, and why they offer limited reassurance: Phase I trial (unpublished): In 2015, a formal Phase I trial on 42 healthy volunteers was initiated to assess BPC-157s safety and pharmacokinetics
This powerful compound has been found to stimulate the proliferation and migration of various skin cells, including keratinocytes, fibroblasts, and endothelial cells, which are crucial for the wound healing process
Klicek, R., Sever, M., Radic, B., Drmic, D., Kocman, I., Zoricic, I.,